Ryan Hasselkus

Ryan Hasselkus is an Associate Scientist at Quris AI, focusing on the development of human PSC-derived in vitro models to enhance the clinical safety predictions of drug candidates. Previously, Ryan served as a Principal Research Associate at Clade Therapeutics, where the differentiation and functionality of engineered hPSC-derived immune cells for cell therapy were key responsibilities. Prior experience includes work as a Senior Research Associate at Sana Biotechnology, specializing in scalable, xeno-free processes for differentiating PSC-derived hepatocytes and pancreatic beta cells, as well as a Research Assistant IV at the Wyss Institute, where human cells were co-cultured in microfluidic devices to mimic organ-specific tissue interfaces. Ryan's academic background includes a Master's degree in Biomedical Engineering from the University of Rochester and a Bachelor's degree in Biomedical Engineering from the University at Buffalo, where notable research focused on the collagen-fibronectin interaction in angiogenesis.